World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
60
Citations
16020
World Ranking
3083
National Ranking
1216

Kenneth E. Sherman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kenneth E. Sherman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 316 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kenneth E. Sherman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth E. Sherman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 60 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kenneth E. Sherman is affiliated with the University of Cincinnati Medical Center in the United States. They have an extensive research portfolio primarily centered on hepatology and related medical fields, contributing significantly to studies on liver diseases, hepatitis viruses, and organ transplantation.

Their recent publications include the following:

  • Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection, 2020, Journal of the American Society of Nephrology
  • Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study, 2020, Journal of Hepatology
  • Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV, 2020, American Journal of Clinical Nutrition
  • Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients, 2020, American Journal of Kidney Diseases
  • Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus, 2023, Clinical Infectious Diseases

Frequent coauthors in their research collaborations include:

  • Javier Tamargo
  • Marianna K. Baum
  • Susan D. Rouster
  • Sabrina Sales Martínez
  • Heidi L. Meeds

Their work has been published repeatedly in the following venues:

  • Gastroenterology
  • Current Developments in Nutrition
  • Clinical Infectious Diseases
  • Liver Transplantation
  • Open Forum Infectious Diseases

Kenneth E. Sherman's research falls mainly within the field of Medicine, with 165 recorded publications. Their subfields of focus include:

  • Hepatology
  • Epidemiology
  • Infectious Diseases
  • Surgery
  • Pharmacology

The primary topics covered in their work are:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • HIV Research and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Organ Transplantation Techniques and Outcomes

Best Publications

  • Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

    Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins

  • Response-guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

    Kenneth K.E. Sherman;Steven S.L. Flamm;Nezam N.H. Afdhal;David Nelson

  • Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

    Kenneth E. Sherman;Susan D. Rouster;Raymond T. Chung;Natasa Rajicic

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Hepatitis C virus infection in USA: an estimate of true prevalence

    Eric W Chak;Andrew H. Talal;Kenneth E. Sherman;Eugene R. Schiff

  • Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

    David L. Wyles;Peter J. Ruane;Mark S. Sulkowski;Douglas Dieterich

  • Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections.

    K E Sherman;J O'Brien;A G Gutierrez;S Harrison

  • Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.

    Mark S Sulkowski;Kenneth E Sherman;Douglas T Dieterich;Mohammad Bsharat

  • Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

    Marion G. Peters;Janet Andersen;Patrick Lynch;Tun Liu

  • Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences

    Jason T. Blackard;Nyingi Kemmer;Kenneth E. Sherman

  • HIV/hepatitis C coinfection natural history and disease progression

    Maria D. Hernandez;Kenneth E. Sherman

  • End-stage liver disease in persons with hemophilia and transfusion-associated infections.

    James J. Goedert;M. Elaine Eyster;Michael M. Lederman;Titica Mandalaki

  • Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus-Infected Patients Following Development of Resistance to or Withdrawal of Lamivudine

    Mary Bessesen;David Ives;Lynn Condreay;Steven Lawrence

  • Acute Hepatitis C Virus Infection: A Chronic Problem

    Jason T. Blackard;M. Tarek Shata;Norah J. Shire;Kenneth E. Sherman

  • Effectiveness of Simeprevir Plus Sofosbuvir, with or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection

    Mark S. Sulkowski;Hugo E. Vargas;Adrian M. Di Bisceglie;Alexander Kuo

  • Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

    James C. Sullivan;Sandra De Meyer;Doug J. Bartels;Inge Dierynck

  • Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.

    Raymond T. Chung;Scott R. Evans;Yijun Yang;Dickens Theodore

  • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

    Norah A. Terrault;Michelle E. Roland;Thomas Schiano;Lorna Dove

  • Nucleoside Analogues and Mitochondrial Toxicity

    Russell Fleischer;Debra Boxwell;Kenneth E. Sherman

  • Occult hepatitis B in HIV-infected patients.

    Norah J. Shire;Susan D. Rouster;Natasa Rajicic;Kenneth E. Sherman

  • Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

    Jurgen Rockstroh;Karine Lacombe;Rolando M Viani;Chloe Orkin

Frequent Co-Authors

Raymond T. Chung
Raymond T. Chung Harvard University
Marion G. Peters
Marion G. Peters University of California, San Francisco
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
Margaret James Koziel
Margaret James Koziel Harvard Medical School
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital
David R. Nelson
David R. Nelson University of Tennessee Health Science Center
Ira M. Jacobson
Ira M. Jacobson New York University
David L. Thomas
David L. Thomas Johns Hopkins University
Andrew J. Muir
Andrew J. Muir Duke University
Norah A. Terrault
Norah A. Terrault University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Microbiology, exploring related fields such as medical coding and health information management can open additional career opportunities. Programs like the cahiim accredited him degree online provide reputable online education for students interested in managing healthcare data effectively.

Many students consider accelerated learning options. The accelerated medical billing and coding certificate online programs offer fast-tracked routes to gain essential skills and certifications, helping individuals enter the workforce quickly.

Certification is key to career advancement. Understanding the cpc salary and career paths can guide microbiology graduates interested in coding to pursue roles with strong financial prospects.

Those aiming for senior positions in healthcare administration should consider the roles of health information managers. Exploring the health information management salary and career trajectories can provide insight into this rewarding profession that complements microbiology expertise.

Best Scientists Citing Kenneth E. Sherman

Trending Scientists

Recently Published Articles